Congenital stationary night blindness (CSNB) implies a stable condition, with the major symptom being nyctalopia present at birth. Pediatric clinical presentation and the course of different genetic subtypes of CSNB have not, to our knowledge, been well described in the era of molecular genetic diagnosis.
C ongenital stationary night blindness (CSNB) is a group of genetically and clinically heterogeneous retinal disorders described as manifesting nonprogressive nyctalopia and an electronegative full-field electroretinogram [ffERG] result. 1 Recently, genetic testing has been added to the diagnostic armamentarium, with at least 17 genes found to be associated with CSNB. 1 This list includes genes encoding proteins involved in phototransduction, photoreceptor to bipolar cell signaling cascades, and retinoid recycling (https://www .omim.org/phenotypicSeries/PS310500). Complete CSNB (cCSNB) can be X-linked or autosomal recessive and is caused by mutations in genes encoding proteins involved in the ON-bipolar signaling cascade, including NYX (Xp11.4; OMIM 300278), 2,3 GRM6 (5q35.3; OMIM 257270), 4 GPR179 (17q12; OMIM 614515), 5,6 LRIT3 (4q25; OMIM 615058), 7 and TRPM1 (15q13.3; OMIM 603576). [8] [9] [10] Patients with cCSNB present with early high myopia, nystagmus, and strabismus. 1, 11 Visual acuity ranges from 20/20 to 20/125, 10, 12, 13 with most patients requiring no academic accommodations due to vision. Not all patients report nyctalopia initially, especially when living in environments with artificial illumination; however, some patients report difficulty navigating in dim light. 11, 12 To our knowledge, accounts of subjective nyctalopia have rarely been stratified based on molecular genetic subtype. In patients who present with moderate to high myopia in early childhood, both primary ocular disorders and systemic disorders associated with myopia are considered. Ocular causes include keratoconus, infantile glaucoma, retinopathy of prematurity, or history of persistent macular hemorrhage. Systemic diagnoses, such as Stickler syndrome, Knobloch syndrome, Cohen syndrome, Ehlers Danlos syndrome type 6, and other connective tissue disorders, including those associated with ectopia lentis, may be investigated. 14, 15 For early-onset nystagmus without apparent ocular cause, neuroimaging is often completed. [16] [17] [18] [19] Unnecessary testing can be avoided by a careful history combined with salient clinical features, ffERG, and molecular confirmation. We present a series of pediatric patients with TRPM1-associated cCSNB who had long-term clinical follow-up starting in infancy or early childhood. To our knowledge, this is one of the first studies to document longitudinal visual function and serial electroretinography and to assess darkadapted (DA) retinal light sensitivity using full-field stimulus threshold testing (FST) in children who have received a molecular diagnosis.
Methods
We obtained approval for a retrospective medical record review from the University of Iowa institutional review board. Written consent for research genetic testing and possible publication had also been obtained on a previous University of Iowa institutional review board approval. Ophthalmologic records of children who presented to the pediatric genetic eye disease service from January 1, 2008, to July 1, 2015, were reviewed. Inclusion criteria were a clinical diagnosis of cCSNB, 2 or more complete eye examinations at least 1 year apart with electroretinography, and TRPM1 variants predicted to be pathologic on genetic testing results.
Clinical information extracted included age at presentation, sex, race/ethnicity, initial diagnosis at presentation, best-corrected visual acuity (BCVA) at age of first optotype acuity and at most recent visit (MRV), initial and final cycloplegic refraction (cyclopentolate, 1%, with retinoscopy at ≥30 minutes postinstallation with manifest in older children), fundoscopic appearance, color vision (Ishihara Color Plates; Kanehara & Co), age at receiving a diagnosis of CSNB, electroretinography (ERG) (Espion E2 V5; Diagnosys), spectral-domain optical coherence tomography of the macula (Spectralis; Heidelberg Engineering), Goldmann visual field results (Haag Streit), and full-field stimulus threshold testing (FST) results (Epsion E; Diagnosys LLC). Parents of preverbal children were routinely asked if their children had difficulty visually locating them in a dark room or tended to cling to parents when walking at night. Older children were asked if they could see the stars at night and whether their eyes took longer to adjust in a dark movie theater or street than their friends'. Full-field ERG testing was conducted in a manner consistent with the International Society for Clinical Electrophysiology of Vision guidelines. 20 Longitudinal changes in amplitudes for DA combined response 3.0 ERG (3.0), light-adapted 3.0 ERG (light-adapted 3.0) and 30 Hz flicker response were analyzed. A linear mixedeffects model was used to compare initial and final amplitudes of the DA 3.0 b wave, light-adapted 3.0 b wave, and 30-Hz flicker amplitudes. Longitudinal changes in myopic refractive error were compared with ERG b-wave amplitude for DA 3.0-and 30-Hz flicker amplitudes for each patient, also using a linear mixed-effects model. Statistical significance was set at P ≤ .05.
Full-field stimulus threshold testing was performed as previously described. 21 (Table 2) . Sibling patients 1 and 2 shared 2 mutations, one known to be pathologic and the other novel and predicted to be pathologic. Sibling patients 3 and 4 were homozygous for mutation c.215A>G (p.Y72C); each parent was heterozygous. Patient 5 had 1 known pathologic mutation and a novel inframe deletion predicted to be pathologic on separate alleles based on parental testing results. Patient 6 had 1 known mutation and 1 variant of uncertain significance. Patient 7 was heterozygous for a reported 1 rare variation predicted by PolyPhen-2 to be deleterious and a large deletion predicted to be deleterious, which are on separate alleles based on parental testing results. Best-corrected visual acuity improved with age ( Figure 1A ). Fundus examination results were similar in all patients, with myopic tilting of the optic nerves, tessellation of the a EPP of 3 and 2 mean chance probability of mutation causing disease is highly likely and possibly likely, respectively. EPP of 0 being a known benign polymorphism, and EPP 1 being a potentially low penetrance or modifying allele. Nucleotide numbering is based on reference sequence of TRPM1 (NM_002420.5), where A of the ATG initiation codon is 1.
posterior pole, and absence of peripheral pigmentary changes ( Figure 2A) . The spectral-domain optical coherence tomography of the macula demonstrated a normal lamination pattern with an intact ellipsoid zone, with staphylomatous excavation in several of the patients ( Figure 2B ). In all patients, Goldmann visual field results were full to Stimulus I4e, with constriction of the I2e isopter in 6 of 7 patients (85.7%). One patient had small central scotomas. Mild constriction of the I2e isopter was found whether patients were tested with glasses or contact lenses ( Figure 2C ; eFigure 1 in the Supplement).
All patients had more than 1 ffERG performed over an average of 44 months (range, 12-60 months). The ERG results were consistent with cCSNB, and ffERGs were almost superimposable among patients ( Figure 2D ; eFigure 2 in the Supplement). All patients demonstrated very low-amplitude DA dim flash (DA 0.01) responses, and electronegative DA bright flash response (DA 3.0) as well as biphasic oscillatory potentials and flattened photopic a-waves (eFigure 2 in the Supplement). When viewed individually, patients 1, 2, and 6 appear to have clinically meaningful decline (≥20%-25% change in amplitudes) in DA 3.0 b wave amplitudes (Figure 3) . However, when analyzed collectively, there was no statistically significant decline in the DA 3.0 b-wave amplitude (95% CI, −20.136 to 23.050; P = .90) or b/a ratio (95% CI, −0.078 to 0.056; P = .76) (Figure 3) . The photopic light-adapted 3.0 b wave amplitude (light-adapted 3.0) and 30-Hz flicker response declined more than the DA amplitudes; however, they were not statistically significant (95% CI, −28.183 to −0.817; P = .06; and 95% CI, −24.552 to −0.264; P = .07, respectively) ( Figure 3) . The decline in DA 3.0 b-wave and 30-Hz flicker amplitudes did not correlate with increase in myopic refraction (95% CI, −0.030 to 0.027; P = .92; and 95% CI, −0.039 to 0.004; P = .16, respectively) after controlling for the association of age. There is a significant association of age with the change in myopic refraction (95% CI, −1.17 to −0.30; P = .01) after controlling for b wave difference (95% CI, −1.02 to −0.14; P = .03 after controlling for 30-Hz difference).
No patient or parent noted nyctalopia at presentation; however, 5 of 7 patients (71%) eventually endorsed some nyctalopia with a mean (SD) age at onset of 6 (3.1) years (range, 2-10 years). Two patients identified it as disrupting their activities, and 3 noted progressive nyctalopia. Dark-adapted FST results were subnormal in all patients who were tested. The mean (SD) FST scores were −29.7 (3.6) dB OU, −29.8 (4.1) dB OD (range, −36 to −22.5), and −28.6 dB OS (range, −35.5 to −26.6) compared with the normal mean (SD) of −59.8 (3.6) dB OD and −59.9 (4.5) dB OS for our laboratory (eFigure 3 in the Supplement). Patients without complaints of nyctalopia did not have different FST results from those who did.
Discussion
Our study describes the pediatric presentation and childhood course of TRPM1-associated cCSNB. This is one of the first reports, to our knowledge, of serial ffERGs and FST testing in children with this disorder. Our data suggest that young children presenting with high myopia, strabismus, and nystagmus should be offered ERG evaluation even in the absence of complaints of night blindness. It is possible that the night vision deficit is only noticed at older ages when more activities are done independently vs a true worsening of night vision. In other disorders with congenital or early-onset night blindness, such as rhodopsin-associated retinitis pigmentosa or RPE65-associated Leber congenital amaurosis (LCA), parents notice from the earliest months of life that the child cannot see them in a dark room; that was not the case for these infants with TRPM1 mutations, although most parents and children noted decreased vision in the dark.
Strengths and Limitations
The limitations of this study that limit the confidence in the definitiveness of the conclusions include the small number of patients evaluated and the retrospective nature of the data collection. TRPM1 encodes the transient receptor potential melastatin 1 (TRPM1) cation channel located in the dendritic tips of ON-bipolar cells. 26 Some mutations, such as splice site, result in loss of TRPM1 function, while some missense mutations lead to a mislocalization of TRPM1. 23 Genotype-phenotype studies will help delineate the mechanisms for specific mutations in TRPM1.
Visual acuity in our cohort at MRV averaged 20/30 in the better-seeing eye (range, 20/20-20/70). Vision improved, likely reflecting improved testing performance with advancing age ( Figure 1A ). The BCVA in this cohort concurs with other studies of patients with cCSNB; 42 however, a range of BCVA from 20/20 to 20/125 has been reported. 10 Our study also concurs with others that report nystagmus diminishing or resolving over time; 48 however, 1 of the patients had large-amplitude, 50 60 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 70 1 10 1 10 10 0 10 1 10 10 1 1 1 1 1 1 1 1 10 0 0  10 10 1 1 1 1 1 1 1 1 1 1 1 1 10 1 1 10 1 1 10 1 A, Typical fundus appearance of a patient with TRPM1 mutations. The right eye demonstrates myopic fundus with tilting of the optic disc and a peripapillary crescent. These features were universal, and no patients had bone spicule-like pigmentation or arteriolar narrowing. B, Spectral-domain optical coherence tomography (OCT) of right eye of patient 5. Note the normal lamination pattern with preservation of the outer retinal layers and staphylomatous excavation of the overall contour. All OCTs were similar. C, Goldmann visual field results for patient 5. Patient 5 demonstrates a small central scotoma and constriction of the I2e isopter. The central scotoma was not uniformly present; however, constriction of the I2e isopter was present in 6 of 7 patients (85.7%) (eFigure 1 in the Supplement). Ok indicates that the area was tested and was within normal limits. D, Representative full-field electroretinography (ERG) waveforms of patient 5 at age 13 years compared with a normal ERG waveform. Note the electronegative standard combined response (dark-adapted [DA] 3.0), biphasic oscillatory potentials and flattened, broad a wave on light-adapted (LA) 3.0 bright flash (LA 3.0). persistent nystagmus that was initially suspected of being opsoclonus. This patient had a gross deletion of 1 copy of TRPM1, which may have led to a more severe phenotype, or the patient's genetic background may have influenced the severity (Table 2) .
No decline between initial and final ERG amplitudes for the group of patients occurred, consistent with a stationary disorder (Figure 3) . Some individual patients, such as patient 1, had a decline in amplitudes over time, which might have led the clinician to suspect photoreceptor degeneration. High intertest variability inherent to ERG (up to 20%-25%) 49 ,50 and our small sample size make interpretation difficult. Some variability was present between siblings sharing identical mutations. Patient 1 exhibited higher and earlier myopia and nystagmus than his sibling, patient 2, but ended with better BCVA and stereopsis and less myopia (Table 1) . Both siblings had strabismus; patient 1 had exotropia and patient 2 had esotropia and fourth nerve palsy. Both complained of progressive nyctalopia. Patient 3 had better retinal sensitivity on FST than sibling patient 4; however, only patient 3 reported nyctalopia.
From the earliest reports of TRPM1-associated cCSNB in humans by Audo et al, 8 high myopia has been consistently reported. Most of the patients presented with horizontal strabismus (esotropia or exotropia) and all had diminished stereopsis. The TRPM1 Appaloosa horse has also been reported to exhibit strabismus.
62,64 To our knowledge, the effect of TRPM1 mutations on the oculomotor system is unknown. Retinal degenerations that decrease peripheral vision often exacerbate phorias or latent strabismus due to loss of peripheral fusion necessary to stabilize ocular alignment; however, the patients had full peripheral visual fields. The synaptic function of TRPM1 may contribute to retinogeniculate projections or other neuroretinal functions that play a role in oculomotor alignment.
Conclusions
The prominence of "night blindness" in the term CSNB should not lead physicians away from considering this diagnosis for children who present with preschool myopia without complaints of nyctalopia, especially if strabismus and/or nystagmus are also present. Full-field electroretinography should be offered, and if a characteristic electronegative pattern is identified, molecular genetic testing of cCSNB genes should be considered. If TRPM1 mutations are present, parents can be counseled to make subtle modifications, such as having children carry a flashlight or cellular phone to provide illumination if the conditions require it. Myopia and subjective nyctalopia may progress over time, while nystagmus may decrease. 
